ICCC (Immucell Corp) Stock Analysis - SEC Filings

Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of May 21, 2026, ICCC trades at $9.88 with a market cap of $89.65M and a P/E ratio of -140.91. ICCC moved -4.90% today. Year to date, ICCC is +63.31%; over the trailing twelve months it is +78.34%. Its 52-week range spans $3.38 to $10.25. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ICCC SEC filings?

Rallies organizes ICCC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ICCC Key Metrics

Key financial metrics for ICCC
MetricValue
Price$9.88
Market Cap$89.65M
P/E Ratio-140.91
EPS$-0.07
Dividend Yield0.00%
52-Week High$10.25
52-Week Low$3.38
Volume0
Avg Volume0
Revenue (TTM)$29.93M
Net Income$-545.40K
Gross Margin42.59%

Latest ICCC News

Recent ICCC Insider Trades

  • te Boekhorst Paul Francis Olivier bought 2.43K (~$13.38K) on Dec 4, 2025.
  • te Boekhorst Paul Francis Olivier bought 3.60K (~$18.15K) on Dec 3, 2025.
  • te Boekhorst Paul Francis Olivier bought 2.56K (~$12.79K) on Dec 3, 2025.

ICCC Analyst Consensus

ICCC analyst coverage data. Average price target: $0.00.

Common questions about ICCC

Where can I find ICCC SEC filings?
Rallies organizes ICCC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ICCC 10-K and 10-Q filings?
Rallies organizes ICCC SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ICCC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ICCC. It does not provide personalized investment advice.
ICCC

ICCC